Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes☆

• 1 January 2004
• journal article
• clinical trial
• Published by Elsevier in Journal of Allergy and Clinical Immunology
• Vol. 113  (1) , 115-119
• https://doi.org/10.1016/j.jaci.2003.10.049

Abstract

Keywords

• IHES
• FIP1-LIKE 1
• FIP1L1
• HES
• ESOPHAGITIS
• HUMANIZED ANTIBODY
• IDIOPATHIC HES
• HIGH-POWER FIELD
• HYPEREOSINOPHILIC SYNDROME
• IL-5
• QOL
• CLINICAL TOXICITY CRITERIA
• EOSINOPHILS
• CYTOKINE
• CTC
• PLATELET-DERIVED GROWTH FACTOR RECEPTOR-Α
• PDGFRA
• EOSINOPHILIC ESOPHAGITIS
• GASTROESOPHAGEAL REFLUX DISEASE
• EE